Saturday, 31 October 2026European Markets

SCANA Stock Was Up By 9.48% Before The Weekend

Loading stream...

(VIANEWS) - The Market ended the session with SCANA (SCANA.OL) jumping 9.48% to kr2.83 on Friday while Oslo Børs Benchmark Index_GI rose 0.48% to kr1,439.44.

SCANA's last close was kr2.59, 0.19% under its 52-week high of kr2.59.

About SCANA

Scana ASA engages in the offshore, energy, and maritime businesses in Norway, rest of European countries, America, Asia, Africa, and Oceania. The company offers valve remote control systems and mooring solutions to vessels, rigs, and floating structures serving the shipping, aquaculture, oil and gas, and energy industries. It also engages in the design and integration of electrical power systems, electrical infrastructure, and energy storage systems and control systems. In addition, the company is involved in the planning and execution of insulation, scaffolding, and surface treatment services; and rig, capping, equipment support, make and break, IMR lifecycle, welding, and asset integrity management services to drilling industry, as well as offers riser applications to the oil and gas industry. Scana ASA was formerly known as Incus Investor ASA and changed its name to Scana ASA in May 2020. The company was founded in 1646 and is headquartered in Bergen, Norway.

Earnings Per Share

As for profitability, SCANA has a trailing twelve months EPS of kr0.23.

PE Ratio

SCANA has a trailing twelve months price to earnings ratio of 12.3. Meaning, the purchaser of the share is investing kr12.3 for every norwegian krone of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 18.92%.

Yearly Top and Bottom Value

SCANA's stock is valued at kr2.83 at 22:33 EST, higher than its 52-week high of kr2.59.

Revenue Growth

Year-on-year quarterly revenue growth grew by 35%, now sitting on 1.75B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, SCANA's stock is considered to be overbought (>=80).

Sales Growth

SCANA's sales growth is 5.7% for the ongoing quarter and 15.7% for the next.

More news about SCANA (SCANA.OL).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com